Search research articles
Contact Us
Filters
Showing results (161-170 of 283) with videos related to
Page
of 29
Sort By:
RMD Open
|
April 22, 2022
Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
Rory C Monahan, Michelle D van den Beukel, Nicole V Borggreven, et al.
Molecular Immunology
|
March 23, 2005
Activation of the lectin pathway in murine lupus nephritis
Leendert A Trouw, Marc A Seelen, Jacques M G J Duijs, et al.
European Journal of Immunology
|
July 13, 2002
Direct binding of C1q to apoptotic cells and cell blebs induces complement activation
Alma J Nauta, Leendert A Trouw, Mohamed R Daha, et al.
Human Immunology
|
October 5, 2011
TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey
Maria I Zervou, Vassilios M Vazgiourakis, Neslihan Yilmaz, et al.
Clinical and Experimental Immunology
|
March 27, 2014
Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease
K A Gelderman, A C A D Drop, L A Trouw, et al.
Clinical and Experimental Immunology
|
December 18, 2003
Anti-C1q autoantibodies in murine lupus nephritis
L A Trouw, M A Seelen, R Visseren, et al.
Autoimmunity Reviews
|
November 2, 2013
Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies
Jing Shi, Peter A van Veelen, Michael Mahler, et al.
Arthritis Research & Therapy
|
August 17, 2012
Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
Anna Foltyn Zadura, Peter F Zipfel, Maria I Bokarewa, et al.
Arthritis and Rheumatism
|
July 1, 2009
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways
L A Trouw, E M Haisma, E W N Levarht, et al.
Annals of the Rheumatic Diseases
|
January 4, 2017
Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands
A van Zanten, S Arends, C Roozendaal, et al.
Page
of 29
Search research articles
Search
Showing results (161-170 of 283) with videos related to
Sort By:
Page
of 29
RMD Open
|
April 22, 2022
Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
Rory C Monahan, Michelle D van den Beukel, Nicole V Borggreven, et al.
Molecular Immunology
|
March 23, 2005
Activation of the lectin pathway in murine lupus nephritis
Leendert A Trouw, Marc A Seelen, Jacques M G J Duijs, et al.
European Journal of Immunology
|
July 13, 2002
Direct binding of C1q to apoptotic cells and cell blebs induces complement activation
Alma J Nauta, Leendert A Trouw, Mohamed R Daha, et al.
Human Immunology
|
October 5, 2011
TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey
Maria I Zervou, Vassilios M Vazgiourakis, Neslihan Yilmaz, et al.
Clinical and Experimental Immunology
|
March 27, 2014
Serum autoantibodies directed against transglutaminase-2 have a low avidity compared with alloantibodies against gliadin in coeliac disease
K A Gelderman, A C A D Drop, L A Trouw, et al.
Clinical and Experimental Immunology
|
December 18, 2003
Anti-C1q autoantibodies in murine lupus nephritis
L A Trouw, M A Seelen, R Visseren, et al.
Autoimmunity Reviews
|
November 2, 2013
Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies
Jing Shi, Peter A van Veelen, Michael Mahler, et al.
Arthritis Research & Therapy
|
August 17, 2012
Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
Anna Foltyn Zadura, Peter F Zipfel, Maria I Bokarewa, et al.
Arthritis and Rheumatism
|
July 1, 2009
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways
L A Trouw, E M Haisma, E W N Levarht, et al.
Annals of the Rheumatic Diseases
|
January 4, 2017
Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands
A van Zanten, S Arends, C Roozendaal, et al.
Page
of 29